September
2026 / 09 / 07
International Day
Still's Disease Awareness Day
Still's Disease Awareness Day aims to raise public awareness and understanding of Still's disease—a rare and serious autoinflammatory disorder. Named after the British physician George Still, the disease can affect both children (systemic juvenile idiopathic arthritis) and adults (adult-onset Still's disease), with typical symptoms including high fever, rash, joint pain, and organ inflammation.
The primary significance of establishing this awareness day lies in: 1) enhancing awareness of this complex disease among the public and the medical community to reduce misdiagnosis; 2) providing support and a sense of community for patients and their families; 3) advocating for increased research funding to improve diagnostic and treatment options.
Typicy, on this day, patient organizations, medical institutions, and advocates worldwide engage in awareness-raising activities through social media campaigns (such as #StillDiseaseAwareness), online seminars, sharing patient stories, releasing educational materials, and illuminating landmark buildings, emphasizing the importance of early diagnosis and comprehensive management.
Companies (especiy those in pharmaceuticals, biotechnology, healthcare, or with corporate social responsibility programs) can leverage this opportunity for public relations communication, for example: sponsoring or co-hosting online health seminars with patient organizations; producing and releasing easy-to-understand educational animations or graphics about the disease; launching social media chenges or hashtags to increase visibility; donating to relevant research projects through corporate foundations; or organizing internal employee education activities to demonstrate care for the rare disease community and social responsibility.
The primary significance of establishing this awareness day lies in: 1) enhancing awareness of this complex disease among the public and the medical community to reduce misdiagnosis; 2) providing support and a sense of community for patients and their families; 3) advocating for increased research funding to improve diagnostic and treatment options.
Typicy, on this day, patient organizations, medical institutions, and advocates worldwide engage in awareness-raising activities through social media campaigns (such as #StillDiseaseAwareness), online seminars, sharing patient stories, releasing educational materials, and illuminating landmark buildings, emphasizing the importance of early diagnosis and comprehensive management.
Companies (especiy those in pharmaceuticals, biotechnology, healthcare, or with corporate social responsibility programs) can leverage this opportunity for public relations communication, for example: sponsoring or co-hosting online health seminars with patient organizations; producing and releasing easy-to-understand educational animations or graphics about the disease; launching social media chenges or hashtags to increase visibility; donating to relevant research projects through corporate foundations; or organizing internal employee education activities to demonstrate care for the rare disease community and social responsibility.
This result was generated by AI